郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.

期刊：Movement disorders : official journal of the Movement Disorder Society发表年份：2011作者：James B Koprich; Susan H Fox; Tom H Johnston; Allan Goodman; Bertrand Le Bourdonnec; Roland E Dolle; Robert N DeHaven; Diane L DeHaven-Hudkins; Patrick J Little; Jonathan M Brotchie
阅读更多 →

药效评价Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.

期刊：Journal of medicinal chemistry发表年份：2011作者：Scott D Kuduk; Ronald K Chang; Christina N Di Marco; Daniel R Pitts; Thomas J Greshock; Lei Ma; Marion Wittmann; Matthew A Seager; Kenneth A Koeplinger; Charles D Thompson; George D Hartman; Mark T Bilodeau; William J Ray
阅读更多 →

药效评价Subtype differences in pre-coupling of muscarinic acetylcholine receptors.

期刊：PloS one发表年份：2011作者：Jan Jakubík; Helena Janíčková; Alena Randáková; Esam E El-Fakahany; Vladimír Doležal
阅读更多 →

药效评价Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant.

期刊：European journal of pharmacology发表年份：2011作者：Pieter Verbost; Willem N Sloot; Ursula M Rose; Renato de Leeuw; Rob G J M Hanssen; Gijs F M Verheijden
阅读更多 →